Pregnancy-induced hypertension caused by all-trans retinoic acid treatment in acute promyelocytic leukemia. A case report
- Authors:
View Affiliations
Affiliations: Department of Hematology, The First Affiliated Hospital of Jishou University, Jishou, Hunan 416000, P.R. China, Department of Pharmacy, The First Affiliated Hospital of Jishou University, Jishou, Hunan 416000, P.R. China
- Published online on: May 7, 2015 https://doi.org/10.3892/ol.2015.3190
-
Pages:
364-366
Metrics: Total
Views: 0 (Spandidos Publications: | PMC Statistics: )
Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )
This article is mentioned in:
Abstract
A 23-year-old pregnant female presented with fever and diarrhea during the sixth month of gestation. The patient was diagnosed with acute promyelocytic leukemia (APL) at 26 weeks gestation and was treated with all‑trans retinoic acid (ATRA) at an initial dose of 45 mg/m2/day, which was reduced to 25 mg/m2/day 14 days later. The patient experienced chest distress, polypnea, hypertension, general dropsy and dysfunction of the kidneys and heart on day 3 of the treatment, which suggested pregnancy‑induced hypertension. Intrauterine fetal demise was apparent on day 8. A cesarean delivery was performed, however, intrauterine fetal mortality had occurred. A favorable outcome was achieved for the patient following treatment, although hematological complete remission was slow. To the best of our knowledge, the present study is the first to describe an APL patient with pregnancy‑induced hypertension following treatment with ATRA, and thus ATRA remains a suitable for therapy for APL during pregnancy.
View References
1
|
Murrin RJ, Adjetey V, Harrison P and
Warwick A: Acute promyelocytic leukaemia presenting as postpartum
haemorrhage. Clin Lab Haematol. 26:233–237. 2004. View Article : Google Scholar : PubMed/NCBI
|
2
|
Tallman MS: The expanding role of arsenic
in acute promyelocytic leukemia. Semin Hematol. 45(3 Suppl 2):
S25–S29. 2008.
|
3
|
Sham RL and Tallman MS: Treatment of acute
promyelocytic leukemia in the very elderly: Case report and review
of the literature. Leuk Res. 28:1347–1350. 2004. View Article : Google Scholar : PubMed/NCBI
|
4
|
Carradice D, Austin N, Bayston K and Ganly
PS: Successful treatment of acute promyelocytic leukaemia during
pregnancy. Clin Lab Haematol. 24:307–311. 2002. View Article : Google Scholar : PubMed/NCBI
|
5
|
Lo-Coco F, Ammatuna E, Montesinos P and
Sanz MA: Acute promyelocytic leukemia: Recent advances in diagnosis
and management. Semin Oncol. 35:401–409. 2008. View Article : Google Scholar : PubMed/NCBI
|
6
|
Fadilah SA, Hatta AZ, Keng CS, Jamil MA
and Singh S: Successful treatment of acute promyelocytic leukemia
in pregnancy with all-trans retinoic acid. Leukemia. 15:1665–1666.
2001. View Article : Google Scholar : PubMed/NCBI
|
7
|
Morimatsu Y, Matsubara S, Hirose N,
Ohkuchi A, Izumi A, Ozaki K, Ozawa K and Suzuki M: Acute
promyelocytic leukemia: An unusual cause showing prolonged
disseminated intravascular coagulation after placental abruption.
Arch Gynecol Obstet. 277:267–270. 2008. View Article : Google Scholar : PubMed/NCBI
|
8
|
Giagounidis AA, Beckmann MW, Giagounidis
AS, Aivado M, Emde T, Germing U, Riehs T, Heyll A and Aul C: Acute
promyelocytic leukemia and pregnancy. Eur J Haematol. 64:267–271.
2000. View Article : Google Scholar : PubMed/NCBI
|
9
|
Tallman MS, Andersen JW, Schiffer CA,
Appelbaum FR, Feusner JH, Ogden A, Shepherd L, Rowe JM, François C,
Larson RS and Wiernik PH: Clinical description of 44 patients with
acute promyelocytic leukemia who developed the retinoic acid
syndrome. Blood. 95:90–95. 2000.PubMed/NCBI
|
10
|
Satpathy HK, Fleming A, Frey D, Barsoom M,
Satpathy C and Khandalavala J: Maternal obesity and pregnancy.
Postgrad Med. 120:E01–E09. 2008.
|
11
|
Alwan S, Polifka JE and Friedman JM:
Angiotensin II receptor antagonist treatment during pregnancy.
Birth Defects Res A Clin Mol Teratol. 73:123–130. 2005. View Article : Google Scholar : PubMed/NCBI
|